Loading...
Engineering and In Vitro Selection of a Novel AAV3B Variant with High Hepatocyte Tropism and Reduced Seroreactivity
Limitations to successful gene therapy with adeno-associated virus (AAV) can comprise pre-existing neutralizing antibodies to the vector capsid that can block cellular entry, or inefficient transduction of target cells that can lead to sub-optimal expression of the therapeutic transgene. Recombinant...
Na minha lista:
| Udgivet i: | Mol Ther Methods Clin Dev |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society of Gene & Cell Therapy
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7591349/ https://ncbi.nlm.nih.gov/pubmed/33145371 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.omtm.2020.09.019 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|